Treatment of venous thromboembolism with rivaroxaban in relation to body weight A sub-analysis of the EINSTEIN DVT/PE studies

Marcello Di Nisio, Maria C. Vedovati, Antoni Riera-Mestre, Martin H. Prins, Katharina Mueller, Alexander T. Cohen, Philip S. Wells, Jan Beyer-Westendorf, Paolo Prandoni, Henri Bounameaux, Dagmar Kubitza, Jonas Schneider, Ron Pisters, Jan Fedacko, Ricardo Fontes-Carvalho, Anthonie W. A. Lensing

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)739-746
JournalThrombosis and Haemostasis
Volume116
Issue number4
DOIs
Publication statusPublished - Oct 2016

Keywords

  • Body mass index
  • bodyweight
  • rivaroxaban
  • venous thromboembolism

Cite this

Di Nisio, M., Vedovati, M. C., Riera-Mestre, A., Prins, M. H., Mueller, K., Cohen, A. T., Wells, P. S., Beyer-Westendorf, J., Prandoni, P., Bounameaux, H., Kubitza, D., Schneider, J., Pisters, R., Fedacko, J., Fontes-Carvalho, R., & Lensing, A. W. A. (2016). Treatment of venous thromboembolism with rivaroxaban in relation to body weight A sub-analysis of the EINSTEIN DVT/PE studies. Thrombosis and Haemostasis, 116(4), 739-746. https://doi.org/10.1160/TH16-02-0087